Easy Archivi - Seite 4 von 4 - Diatech

21 07, 2020

Umberto Malapelle et. al., Predictive molecular pathology in the time of coronavirus disease

Diatech Pharmacogenetics2020-07-21T14:11:03+02:00

16 05, 2020

Alessandro Parisi et. al., Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study

Diatech Pharmacogenetics2020-11-03T15:11:22+01:00

15 05, 2020

Ilaria Proietti et. al., A rare BRAF V600E mutation detected by next-generation sequencing in a superficial spreading melanoma: case report and potential diagnostic implications

Diatech Pharmacogenetics2020-11-03T15:59:46+01:00

16 12, 2019

M.Lucia Reale et. al., Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients

Diatech Pharmacogenetics2019-12-16T16:06:13+01:00

11 06, 2019

Ilaria Francaviglia et al., Identification and monitoring of somatic mutations in circulating cell-free tumor DNA in lung cancer patients

Diatech Pharmacogenetics2019-06-11T09:44:31+02:00

26 05, 2019

Libor Stanek et al., Expression level of NRP1 and SMAD2 in correlation to mutational status of RAS (BRAF) in pancreatic cancer.

Diatech Pharmacogenetics2019-05-26T14:06:00+02:00

27 04, 2019

Mariella Dono et al., Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients

Diatech Pharmacogenetics2019-04-27T08:41:07+02:00

18 03, 2019

Riccardo Giannini et al., Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: an ATC-like and a PDTC-like

Diatech Pharmacogenetics2019-03-18T12:19:27+01:00

22 02, 2019

Mohammad A. Al Hamad et al., BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review.

Diatech Pharmacogenetics2019-02-22T09:11:35+01:00

12 01, 2018

Elena Bonaparte et. al, Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry

Diatech Pharmacogenetics2018-01-12T13:41:10+01:00